Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry.
Saladini F, Giammarino F, Maggiolo F, Ferrara M, Cenderello G, Celesia BM, Martellotta F, Spagnuolo V, Corbelli GM, Gianotti N, Santoro MM, Rusconi S, Zazzi M, Castagna A; PRESTIGIO Study Group. Saladini F, et al. Among authors: celesia bm. Int J Antimicrob Agents. 2023 Mar;61(3):106737. doi: 10.1016/j.ijantimicag.2023.106737. Epub 2023 Jan 25. Int J Antimicrob Agents. 2023. PMID: 36708743
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project).
Menzaghi B, Ricci E, Carenzi L, Parruti G, Orofino G, Guastavigna M, Madeddu G, Maggi P, Di Biagio A, Corsi P, Penco G, De Socio G, Martinelli C, Vichi F, Celesia BM, Franzetti M, Grosso C, Molteni C, Bonfanti P, Quirino T. Menzaghi B, et al. Among authors: celesia bm. Biomed Pharmacother. 2013 May;67(4):293-8. doi: 10.1016/j.biopha.2012.12.005. Epub 2012 Dec 26. Biomed Pharmacother. 2013. PMID: 23433852 Clinical Trial.
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study.
Nozza S, Malagoli A, Maia L, Calcagno A, Focà E, De Socio G, Piconi S, Orofino G, Cattelan AM, Celesia BM, Gervasi E, Guaraldi G; GEPPO Study Group. Nozza S, et al. Among authors: celesia bm. J Antimicrob Chemother. 2017 Oct 1;72(10):2961. doi: 10.1093/jac/dkx282. J Antimicrob Chemother. 2017. PMID: 29091220 No abstract available.
Non-AIDS defining cancers: a comprehensive update on diagnosis and management.
Ceccarelli M, Venanzi Rullo E, Marino MA, d'Aleo F, Pellicanò GF, D'Andrea F, Marino A, Cacopardo B, Celesia BM, La Rocca G, Di Rosa M, Condorelli F, Berretta M, Nunnari G. Ceccarelli M, et al. Among authors: celesia bm. Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):3849-3875. doi: 10.26355/eurrev_202004_20852. Eur Rev Med Pharmacol Sci. 2020. PMID: 32329861 Free article. Review.
Serum tumor necrosis factor in acute and fulminant hepatitis B.
Cacopardo B, Fatuzzo F, Russo R, Celesia BM, La Rosa R, Lupo G, Cosentino S, Nunnari A. Cacopardo B, et al. Among authors: celesia bm. J Infect Dis. 1992 Aug;166(2):448-9. doi: 10.1093/infdis/166.2.448. J Infect Dis. 1992. PMID: 1634817 No abstract available.
The undesired fellow traveller.
Guarneri C, Mughini M, Celesia B, Massimino D, Nunnari G. Guarneri C, et al. QJM. 2012 Jul;105(7):697-8. doi: 10.1093/qjmed/hcr067. Epub 2011 May 4. QJM. 2012. PMID: 21543448 No abstract available.
136 results